-
Something wrong with this record ?
Expanding the Molecular-genetic Spectrum of Canalicular Adenoma-like Subtype of Pleomorphic Adenoma of Salivary Glands
N. Klubíčková, F. Loghides, MFCM. van den Hout, V. Costes-Martineau, G. Ferrara, M. Rito, V. Hájková, P. Grossmann, P. Šteiner, I. Kovářová, M. Michal, I. Leivo, A. Skálová
Language English Country United States
Document type Journal Article
Grant support
LX22NPO5102
Next Generation EU - European Union
Turku University Hospital Fund
Maritza and Reino Salonen
- MeSH
- Adult MeSH
- Phenotype MeSH
- Genetic Predisposition to Disease MeSH
- Gene Rearrangement * MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Biomarkers, Tumor * genetics analysis MeSH
- Salivary Gland Neoplasms * genetics pathology chemistry MeSH
- Adenoma, Pleomorphic * genetics pathology chemistry MeSH
- HMGA2 Protein * genetics MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
Canalicular tumors of the salivary glands have recently emerged as an entity characterized by distinct morphology and recurrent HMGA2 gene rearrangement. In this study, we analyzed 40 cases intending to elucidate their features further. The monophasic or biphasic tumors exhibited a growth pattern of interconnected anastomosing trabeculae and canaliculi, accompanied by a classical pleomorphic adenoma in one-third of the cases. Invasive growth into surrounding adipose tissue was revealed in one case which was, therefore, diagnosed as epithelial-myoepithelial carcinoma. Although the tumor cells uniformly expressed HMGA2 protein in all cases, cytokeratin 7, S100 protein, and SOX10 displayed either diffuse positivity or highlighted the luminal and abluminal cell populations, respectively. Areas with morphological oncocytoid change and AR-immunopositivity of luminal cells were seen in 13/14 (93%) of tested biphasic cases. HMGA2 rearrangement was detected by RNA-sequencing in 30 cases. The most common alteration was an HMGA1::WIF1 fusion, but several novel or rare fusion partners were identified, including ARID2 , FHIT , MSRB3 and its antisense variant MSRB3-AS1 , IFNG-AS1 , and the long intergenic region LINC02389 . In addition, FISH revealed HGMA2 break-apart in the remaining 10 cases where targeted sequencing failed to detect any alteration or where RNA sequencing could not be performed. Notably, the loss of the 3'-untranslated region of HMGA2 emerges as the common denominator for the described rearrangements, possibly disrupting its negative regulation by small regulatory RNAs. Awareness of this lesion ensures appropriate diagnosis and clinical management, especially with regard to the possibility of malignant transformation described in this and previous studies.
Biomedical Center Faculty of Medicine in Pilsen Charles University Czech Republic
Bioptical Laboratory Ltd Pilsen Czech Republic
Department of Pathology University Hospital of Montpellier Montpellier France
Faculdade de Medicina Instituto de Anatomia Patológica Universidade de Lisboa Lisbon Portugal
Serviço de Anatomia Patológica Instituto Português de Oncologia de Lisboa Portugal
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25015543
- 003
- CZ-PrNML
- 005
- 20250731091049.0
- 007
- ta
- 008
- 250708s2025 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1097/PAS.0000000000002377 $2 doi
- 035 __
- $a (PubMed)40033554
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Klubíčková, Natálie $u Department of Pathology, University Hospital and Faculty of Medicine in Pilsen, Charles University, Czech Republic $u Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Czech Republic $u Bioptical Laboratory, Ltd., Pilsen, Czech Republic $1 https://orcid.org/0000000244075544
- 245 10
- $a Expanding the Molecular-genetic Spectrum of Canalicular Adenoma-like Subtype of Pleomorphic Adenoma of Salivary Glands / $c N. Klubíčková, F. Loghides, MFCM. van den Hout, V. Costes-Martineau, G. Ferrara, M. Rito, V. Hájková, P. Grossmann, P. Šteiner, I. Kovářová, M. Michal, I. Leivo, A. Skálová
- 520 9_
- $a Canalicular tumors of the salivary glands have recently emerged as an entity characterized by distinct morphology and recurrent HMGA2 gene rearrangement. In this study, we analyzed 40 cases intending to elucidate their features further. The monophasic or biphasic tumors exhibited a growth pattern of interconnected anastomosing trabeculae and canaliculi, accompanied by a classical pleomorphic adenoma in one-third of the cases. Invasive growth into surrounding adipose tissue was revealed in one case which was, therefore, diagnosed as epithelial-myoepithelial carcinoma. Although the tumor cells uniformly expressed HMGA2 protein in all cases, cytokeratin 7, S100 protein, and SOX10 displayed either diffuse positivity or highlighted the luminal and abluminal cell populations, respectively. Areas with morphological oncocytoid change and AR-immunopositivity of luminal cells were seen in 13/14 (93%) of tested biphasic cases. HMGA2 rearrangement was detected by RNA-sequencing in 30 cases. The most common alteration was an HMGA1::WIF1 fusion, but several novel or rare fusion partners were identified, including ARID2 , FHIT , MSRB3 and its antisense variant MSRB3-AS1 , IFNG-AS1 , and the long intergenic region LINC02389 . In addition, FISH revealed HGMA2 break-apart in the remaining 10 cases where targeted sequencing failed to detect any alteration or where RNA sequencing could not be performed. Notably, the loss of the 3'-untranslated region of HMGA2 emerges as the common denominator for the described rearrangements, possibly disrupting its negative regulation by small regulatory RNAs. Awareness of this lesion ensures appropriate diagnosis and clinical management, especially with regard to the possibility of malignant transformation described in this and previous studies.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a nádory slinných žláz $x genetika $x patologie $x chemie $7 D012468
- 650 12
- $a pleomorfní adenom $x genetika $x patologie $x chemie $7 D008949
- 650 12
- $a protein HMGA2 $x genetika $7 D025743
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a nádorové biomarkery $x genetika $x analýza $7 D014408
- 650 _2
- $a dospělí $7 D000328
- 650 12
- $a genová přestavba $7 D015321
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a mladý dospělý $7 D055815
- 650 _2
- $a fenotyp $7 D010641
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a genetická predispozice k nemoci $7 D020022
- 650 _2
- $a senioři nad 80 let $7 D000369
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Loghides, Frederica $u Department of Anatomical Pathology, Canterbury District Health Board, Christchurch Hospital, Christchurch, New Zealand
- 700 1_
- $a van den Hout, Mari F C M $u Department of Pathology, School for Oncology and Reproduction (GROW), Maastricht University Medical Center, Maastricht, The Netherlands
- 700 1_
- $a Costes-Martineau, Valérie $u Department of Pathology, University Hospital of Montpellier, Montpellier, France $u REFCORpath, France
- 700 1_
- $a Ferrara, Gerardo $u Anatomic Pathology and Cytopathology Unit, Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', Via Mariano Semmola, Naples, Italy
- 700 1_
- $a Rito, Miguel $u Serviço de Anatomia Patológica, Instituto Português de Oncologia de Lisboa, Portugal $u Faculdade de Medicina, Instituto de Anatomia Patológica, Universidade de Lisboa, Lisbon, Portugal
- 700 1_
- $a Hájková, Veronika $u Bioptical Laboratory, Ltd., Pilsen, Czech Republic
- 700 1_
- $a Grossmann, Petr $u Bioptical Laboratory, Ltd., Pilsen, Czech Republic
- 700 1_
- $a Šteiner, Petr $u Bioptical Laboratory, Ltd., Pilsen, Czech Republic
- 700 1_
- $a Kovářová, Inka $u Department of Pathology, University Hospital and Faculty of Medicine in Pilsen, Charles University, Czech Republic
- 700 1_
- $a Michal, Michal $u Department of Pathology, University Hospital and Faculty of Medicine in Pilsen, Charles University, Czech Republic $u Bioptical Laboratory, Ltd., Pilsen, Czech Republic
- 700 1_
- $a Leivo, Ilmo $u Institute of Biomedicine, Pathology, University of Turku and Department of Pathology, Turku University Hospital, Turku, Finland
- 700 1_
- $a Skálová, Alena $u Department of Pathology, University Hospital and Faculty of Medicine in Pilsen, Charles University, Czech Republic $u Bioptical Laboratory, Ltd., Pilsen, Czech Republic
- 773 0_
- $w MED00000304 $t The American journal of surgical pathology $x 1532-0979 $g Roč. 49, č. 6 (2025), s. 554-563
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/40033554 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250708 $b ABA008
- 991 __
- $a 20250731091043 $b ABA008
- 999 __
- $a ok $b bmc $g 2366408 $s 1252668
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 49 $c 6 $d 554-563 $e 20250304 $i 1532-0979 $m The American journal of surgical pathology $n Am J Surg Pathol $x MED00000304
- GRA __
- $a LX22NPO5102 $p Next Generation EU - European Union
- GRA __
- $a Turku University Hospital Fund $p Maritza and Reino Salonen
- LZP __
- $a Pubmed-20250708